WaveMan · Form 4
Akkaraju Srinivas insider trades
> Search tickers & screens ⌘K
LIVE

Akkaraju Srinivas insider trades

Akkaraju Srinivas has filed 68 Form 4s with the SEC that we hold, for Alumis INC. (ALMS) (Director), Scholar Rock Holding Corp (SRRK) (Director), SYRS (Director) and vTv Therapeutics Inc. (VTVT) (Director), among 12 companies in all. Across all of them we count 56 purchases worth $185.9M and 5 sales worth $35.4M reported on Form 4. In the last 12 months: 18 purchases ($27.3M) and 2 sales ($1.0M). The largest single trade was a purchase of 1,562,500 shares of Alumis INC. worth $25.0M, dated 2024-07-01. Of 2 sales filed since we began reading the 10b5-1 checkbox, 0 (0%) were marked as made under a 10b5-1 trading plan. The first filing on our record is dated 2021-07-01 and the latest 2026-09-09.

Alumis INC. (ALMS)

Director · 14 filings · 24 purchases and sales
Trade dateCodeSharesValue as filedFiled
2024-07-01P, purchase reported on Form 41,562,500$25.0M2024-08-27
2025-05-02P, purchase reported on Form 4159,920$727.6K2025-05-06
2025-05-05P, purchase reported on Form 422,002$116.0K2025-05-06
2025-05-05P, purchase reported on Form 4138,368$633.7K2025-05-06
2025-11-13P, purchase reported on Form 4276,179$1.4M2025-11-17
2025-11-17P, purchase reported on Form 4914$5.0K2025-11-19
2025-11-18P, purchase reported on Form 4102,652$621.0K2025-11-19
2025-11-19P, purchase reported on Form 4137,772$903.8K2025-11-19
2025-11-20P, purchase reported on Form 4125,743$905.3K2025-11-24
2025-11-26P, purchase reported on Form 448,537$370.8K2025-12-01
2025-11-28P, purchase reported on Form 438,702$295.7K2025-12-01
2025-12-01P, purchase reported on Form 486,350$644.2K2025-12-01
2025-12-02P, purchase reported on Form 496,000$724.8K2025-12-04
2025-12-03P, purchase reported on Form 4100,000$775.0K2025-12-04
2025-12-04P, purchase reported on Form 466,027$540.1K2025-12-04
2025-12-05P, purchase reported on Form 470,028$701.0K2025-12-09
2025-12-05P, purchase reported on Form 451,380$551.3K2025-12-09
2025-12-05P, purchase reported on Form 464,969$581.5K2025-12-09
2026-01-09P, purchase reported on Form 4588,235$10.0M2026-01-13
2026-09-04P, purchase reported on Form 4220,070$2.5M2026-09-09
2026-09-08S, sale reported on Form 448,066$507.0K2026-09-09
2026-09-08S, sale reported on Form 448,065$507.0K2026-09-09
2026-09-08P, purchase reported on Form 4273,291$2.9M2026-09-09
2026-09-08P, purchase reported on Form 4273,290$2.9M2026-09-09

Scholar Rock Holding Corp (SRRK)

Director · 9 filings · 13 purchases and sales
Trade dateCodeSharesValue as filedFiled
2023-10-16P, purchase reported on Form 42,189,781$15.0M2023-10-18
2024-10-07S, sale reported on Form 4155,713$5.1M2024-10-07
2024-10-07S, sale reported on Form 4510,000$14.0M2024-10-07
2024-10-07S, sale reported on Form 4510,000$15.3M2024-10-07
2025-10-03P, purchase reported on Form 4319,700$12.0M2025-10-07
2025-10-03P, purchase reported on Form 456,703$2.1M2025-10-07
2025-10-03P, purchase reported on Form 411,011$392.1K2025-10-07
2025-10-06P, purchase reported on Form 418,414$697.7K2025-10-07
2025-10-06P, purchase reported on Form 413,748$543.3K2025-10-07
2025-10-06P, purchase reported on Form 480,863$3.1M2025-10-07
2025-10-07P, purchase reported on Form 44,403$180.4K2025-12-16
2025-10-07P, purchase reported on Form 412,796$503.0K2025-12-16
2025-10-07P, purchase reported on Form 412,400$498.2K2025-12-16

SYRS

Director · 8 filings · 1 purchase or sale
Trade dateCodeSharesValue as filedFiled
2023-12-21P, purchase reported on Form 4904,977$4.0M2023-12-26

vTv Therapeutics Inc. (VTVT)

Director · 8 filings · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

KDNY

Director · 6 filings · 3 purchases and sales
Trade dateCodeSharesValue as filedFiled
2021-08-18P, purchase reported on Form 4208,500$2.5M2021-08-20
2021-11-15P, purchase reported on Form 41,215,000$17.0M2021-11-17
2022-05-27P, purchase reported on Form 4570,000$8.0M2022-06-01

LENZ Therapeutics, Inc. (GRPH)

10% owner · 6 filings · 12 purchases and sales
Trade dateCodeSharesValue as filedFiled
2021-06-29P, purchase reported on Form 415,000$255.0K2021-07-01
2021-06-29P, purchase reported on Form 4485,000$8.2M2021-07-01
2021-10-06P, purchase reported on Form 461,475$850.2K2021-10-08
2021-10-07P, purchase reported on Form 49,021$134.8K2021-10-08
2021-10-08P, purchase reported on Form 475,000$984.0K2021-10-08
2021-11-22P, purchase reported on Form 4201,685$2.0M2021-11-24
2022-01-19P, purchase reported on Form 454,565$504.2K2022-01-21
2022-01-20P, purchase reported on Form 443,105$384.5K2022-01-21
2022-01-21P, purchase reported on Form 4100,000$899.0K2022-01-25
2022-01-24P, purchase reported on Form 423,000$200.1K2022-01-25
2022-04-11P, purchase reported on Form 474,464$303.1K2022-04-13
2022-04-12P, purchase reported on Form 4350,000$1.4M2022-04-13

Mineralys Therapeutics, Inc. (MLYS)

Director, 10% owner · 6 filings · 3 purchases and sales
Trade dateCodeSharesValue as filedFiled
2023-02-14P, purchase reported on Form 4937,500$15.0M2023-02-16
2025-03-13P, purchase reported on Form 4600,000$8.1M2025-03-17
2025-09-04P, purchase reported on Form 4588,235$15.0M2025-09-08

Kalaris Therapeutics, Inc. (KLRS)

Director · 4 filings · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

ICPT

Director · 3 filings · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

JYAC

Director, 10% owner · 2 filings · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

CRGX

10% owner · 1 filing · 1 purchase or sale
Trade dateCodeSharesValue as filedFiled
2023-11-14P, purchase reported on Form 4666,666$10.0M2023-11-16

Neurogene Inc. (NGNE)

10% owner · 1 filing · 4 purchases and sales
Trade dateCodeSharesValue as filedFiled
2024-11-26P, purchase reported on Form 42,000$55.0K2024-11-27
2024-11-26P, purchase reported on Form 415,219$406.8K2024-11-27
2024-11-26P, purchase reported on Form 410,803$281.0K2024-11-27
2024-11-26P, purchase reported on Form 420,748$516.8K2024-11-27
Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1253170) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-12 · For informational purposes only, not investment advice.
Privacy · Terms